Stockscreener 앱 받기
0.42%
시간 외 거래:
전일 마감가:
$150.68
열려 있는:
$150.46
하루 거래량:
456.03K
Relative Volume:
0.43
시가총액:
$10.03B
수익:
$13.64B
순이익/손실:
$1.05B
주가수익비율:
15.70
EPS:
9.555
순현금흐름:
$1.31B
1주 성능:
+3.07%
1개월 성능:
-0.99%
6개월 성능:
+21.02%
1년 성능:
-2.16%
1일 변동 폭
$149.26
$151.30
1주일 범위
$144.76
$153.00
52주 변동 폭
$101.00
$159.42
다비타 Stock (DVA) Company Profile
명칭
Davita Inc
전화
310-536-2668
주소
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
150.05 | 10.07B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
495.47 | 113.39B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
195.24 | 17.56B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
23.63 | 13.19B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
199.02 | 11.77B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
180.78 | 11.47B | 17.36B | 1.51B | 849.25M | 23.15 |
다비타 Stock (DVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-08-07 | 업그레이드 | UBS | Neutral → Buy |
| 2022-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-08-19 | 재개 | UBS | Buy |
| 2022-06-21 | 재확인 | BofA Securities | Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-12 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2018-12-14 | 개시 | Barclays | Overweight |
| 2018-11-28 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 개시 | UBS | Sell |
| 2018-11-08 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-12-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-12-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
다비타 주식(DVA)의 최신 뉴스
DaVitaFurther Upside Is Trickier (Rating Downgrade) (NYSE:DVA) - Seeking Alpha
DaVita Inc. stock (US23918K1088): Is its dialysis dominance strong enough to unlock new upside? - AD HOC NEWS
Here's why you should retain DaVita stock in your portfolio for now - MSN
DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Reasons to Keep DaVita Stock in Your Investment Portfolio at This Time - Bitget
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - TradingView
Zacks Downgrades DaVita Stock Rating - National Today
DaVita Inc stock: What investors need to know about its dialysis dominance now - AD HOC NEWS
California law limiting dialysis providers' profits voided by US appeals court - Reuters
DaVita Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse - CSRwire
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - csrwire.com
Day in the Life: Jena, DaVita Social Worker - CSRwire
Day in the Life: Cristina, DaVita PD Registered Nurse - CSRwire
DVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
DaVita Inc. stock underperforms Thursday when compared to competitors - MSN
DaVita Inc. (DVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Inc. (DVA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Entities’ Drug Purchases Exempt From Louisiana Sales Tax - news.bloombergtax.com
DaVita Inc. stock: Steady earnings beat amid market dips—what's next? - AD HOC NEWS
DaVita Arms Freed From Local La. Tax On Medicare Drugs - Law360
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
DaVita Inc Stock: Leading Dialysis Provider Faces Evolving Healthcare Landscape in 2026 - AD HOC NEWS
DaVita: A Digital Guardian: AI-Powered Insights Bring Patients and Clinicians Closer - FinanzNachrichten.de
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market - Yahoo Finance
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health - GlobeNewswire Inc.
Assenagon Asset Management Trims DaVita Stake - National Today
Assenagon Asset Management S.A. Trims Holdings in DaVita Inc. $DVA - MarketBeat
DaVita stock dips 1.49% as company promotes home dialysis benefits - Traders Union
Wedge Capital Management L L P NC Purchases 45,998 Shares of DaVita Inc. $DVA - MarketBeat
SG Americas Securities LLC Increases Stake in DaVita Inc. $DVA - MarketBeat
DaVita (FRA:TRL) PB Ratio : (As of Mar. 28, 2026) - GuruFocus
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why DaVita Inc (DVA) Is Set to Outperform the Market: Insights i - GuruFocus
DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Vanguard disaggregates holdings; DVA shows 0 shares (DVA) - Stock Titan
DaVita tops chart as the only large-cap healthcare services name rated strong buy - msn.com
Research Alert: CFRA Raises Rating On Shares Of Davita Inc. To Buy From Hold - Moomoo
DaVita Inc. stock faces scrutiny amid dialysis sector reimbursement pressures and Medicare policy sh - AD HOC NEWS
Working Together: DaVita Celebrates Joint Efforts To Advance Kidney Health Awareness and Access to Care - CSRwire
Flexibility of a Home Dialysis Nurse - CSRwire
Nordea Investment Management AB Boosts Holdings in DaVita Inc. $DVA - MarketBeat
다비타 (DVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.00%
0.08%
자본화:
|
볼륨(24시간):